We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals

28 hedge funds and large institutions have $8.36M invested in Cumberland Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.09% less ownership

Funds ownership: 21.62%19.53% (-2.1%)

10% less funds holding

Funds holding: 3128 (-3)

14% less capital invested

Capital invested by funds: $9.77M → $8.36M (-$1.41M)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
4
Reduced
11
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$1K
Citadel Advisors
27
Citadel Advisors
Florida
-$52K -17,005 Closed
MHS
28
M Holdings Securities
Oregon
-$33K -10,750 Closed
Bank of America
29
Bank of America
North Carolina
-$7.56K -2,570 -94%
WCM
30
Wealthcare Capital Management
Virginia
-$1K -185 Closed

CPIX Hedge Fund Activity: Q2 2021 in Review

28 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2021, worth a combined $8.36M — down 14% from $9.77M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CPIX and 0 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 4 added.

The largest buyer was BlackRock, adding an estimated $95.8K. The largest seller was Ariel Investments, cutting an estimated $589K.

  • 28 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2021, down from 31 in Q1 2021.
  • Funds reported $8.36M of Cumberland Pharmaceuticals stock for Q2 2021, down 14% quarter-over-quarter.
  • 0 funds opened new Cumberland Pharmaceuticals positions in Q2 2021 and 3 closed out, a net change of -3 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q2 2021 was BlackRock, an estimated $95.8K added.
  • The largest Cumberland Pharmaceuticals seller in Q2 2021 was Ariel Investments, an estimated $589K sold.

Based on aggregated 13F filings for Q2 2021.